mecodiagnostics.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: | ||
Meta Tags
| Title | MeCo |
| Description | ~25% of breast tumors can be targeted with a new therapeutic Home Team News Technology Science Publications Contact Us ~25% of breast tumors can be targeted with a new therapeutic strategy ~25% of breast tumors can |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 76.223.105.230 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
mecodiagnostics.com Valuation
|
US$1,005
Last updated: 2023-05-20 05:17:01
mecodiagnostics.com has Semrush global rank of 0. mecodiagnostics.com has an estimated worth of US$ 1,005, based on its estimated Ads revenue. mecodiagnostics.com receives approximately 116 unique visitors each day. Its web server is located in United States, with IP address 76.223.105.230. According to SiteAdvisor, mecodiagnostics.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,005 |
| Daily Ads Revenue | US$0 |
| Monthly Ads Revenue | US$27 |
| Yearly Ads Revenue | US$334 |
| Daily Unique Visitors | 7 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| mecodiagnostics.com. | A | 3599 | IP: 76.223.105.230 |
| mecodiagnostics.com. | A | 3599 | IP: 13.248.243.5 |
| mecodiagnostics.com. | NS | 3600 | NS Record: ns12.domaincontrol.com. |
| mecodiagnostics.com. | NS | 3600 | NS Record: ns11.domaincontrol.com. |
| mecodiagnostics.com. | MX | 3600 | MX Record: 0 mecodiagnostics-com.mail.protection.outlook.com. |
| mecodiagnostics.com. | TXT | 3600 | TXT Record: v=spf1 include:secureserver.net -all |
| mecodiagnostics.com. | TXT | 3600 | TXT Record: NETORGFT8532768.onmicrosoft.com |
HtmlToTextCheckTime:2023-05-20 05:17:01
| Home Team News Technology Science Publications Contact Us ~25% of breast tumors can be targeted with a new therapeutic strategy ~25% of breast tumors can be targeted with a new therapeutic strategy ~25% of breast tumors can be targeted with a new therapeutic strategy ~25% of breast tumors can be targeted with a new therapeutic strategy Our technology reveals if you’re a match for a low-toxicity, repurposed drug that will soon emerge as a low-cost generic Learn more Home Team News Technology Science Publications Contact Us Copyright © 2022 MeCo Diagnostics Holdings, Inc. - All Rights Reserved. |
HTTP Headers
HTTP/1.1 301 Moved Permanently location: https://mecodiagnostics.com/ vary: Accept-Encoding server: DPS/2.0.0-beta+sha-234f661 x-version: 234f661 x-siteid: eu-central-1 set-cookie: dps_site_id=eu-central-1; path=/ etag: 68829da16a723a67052bd042b70bec55 date: Thu, 12 Jan 2023 08:46:35 GMT keep-alive: timeout=5 HTTP/2 200 cache-control: max-age=30 content-security-policy: frame-ancestors 'self' godaddy.com *.godaddy.com content-type: text/html;charset=utf-8 vary: Accept-Encoding server: DPS/2.0.0-beta+sha-234f661 x-version: 234f661 x-siteid: eu-central-1 set-cookie: dps_site_id=eu-central-1; path=/; secure etag: 68829da16a723a67052bd042b70bec55 date: Thu, 12 Jan 2023 08:46:35 GMT |